跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,702 条关于
“Angelman Syndrome Foundation”
全部
32,702
临床试验
25,345
药物
295
机构
485
资讯
6,577
上个月
Angelman Syndrome Foundation and Citizen Health Partner to Bring AI Advocate Ari to Angelman Families
去年
Ultragenyx Doses First Patient in Phase 3 Aspire Study of GTX-102 for Angelman Syndrome
12个月前
FDA Grants Fast Track Designation to MavriX Bio's MVX-220 Gene Therapy for Angelman Syndrome
去年
FDA Clears IND for MavriX Bio's Gene Therapy for Angelman Syndrome, First-in-Human Trial to Begin in 2025
去年
Oak Hill Bio Advances Rugonersen for Angelman Syndrome Following Promising Phase 1 Results Published in Nature Medicine
去年
Ionis Advances Antisense Therapy for Angelman Syndrome to Phase 3 Following Promising Clinical Results
去年
Ionis Pharmaceuticals Highlights Pipeline Progress and Financial Results in Q3 2024
去年
Ionis Pharmaceuticals Highlights Pipeline Progress and Financials in Q3 2024
去年
Ionis Pharmaceuticals Advances Pipeline with Key Regulatory and Clinical Milestones
去年
Ultragenyx's GTX-102 Shows Promise in Angelman Syndrome Phase 1/2 Data
第 1 页，共 658 页
上一页
下一页
